GoodRx Holdings, Inc.
GDRX
$4.43
-$0.045-1.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 198.58M | 195.25M | 200.61M | 197.88M | 196.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 198.58M | 195.25M | 200.61M | 197.88M | 196.64M |
| Cost of Revenue | 12.19M | 11.68M | 11.87M | 12.47M | 10.67M |
| Gross Profit | 186.39M | 183.57M | 188.74M | 185.41M | 185.97M |
| SG&A Expenses | 97.02M | 115.49M | 121.04M | 118.07M | 107.69M |
| Depreciation & Amortization | 19.10M | 17.54M | 16.97M | 15.94M | -3.09M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.05M | 174.84M | 180.73M | 177.50M | 137.90M |
| Operating Income | 38.54M | 20.41M | 19.88M | 20.38M | 58.74M |
| Income Before Tax | 11.41M | 8.11M | 11.65M | 293.00K | -24.64M |
| Income Tax Expenses | 4.67M | 4.15M | 4.95M | 1.30M | 1.23M |
| Earnings from Continuing Operations | 6.74M | 3.97M | 6.69M | -1.01M | -25.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.74M | 3.97M | 6.69M | -1.01M | -25.87M |
| EBIT | 38.54M | 20.41M | 19.88M | 20.38M | 58.74M |
| EBITDA | 41.87M | 37.94M | 36.84M | 36.32M | 63.01M |
| EPS Basic | 0.02 | 0.01 | 0.02 | 0.00 | -0.06 |
| Normalized Basic EPS | 0.05 | 0.02 | 0.02 | 0.02 | 0.08 |
| EPS Diluted | 0.02 | 0.01 | 0.02 | 0.00 | -0.06 |
| Normalized Diluted EPS | 0.05 | 0.02 | 0.02 | 0.02 | 0.08 |
| Average Basic Shares Outstanding | 381.61M | 379.67M | 376.25M | 390.05M | 403.25M |
| Average Diluted Shares Outstanding | 383.58M | 388.50M | 384.73M | 390.05M | 403.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
